Human medicines European Public Assessment Report (EPAR): Abraxane, paclitaxel, Revision: 8, Authorised
11:30 EDT 13 Jul 2012 | European Medicines Agency
Original Article: Human medicines European Public Assessment Report (EPAR): Abraxane, paclitaxel, Revision: 8, Authorised
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): Abraxane, paclitaxel, Revision: 8, Authorised"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
